4-farnesyloxycoumarin

4-farnesyloxycoumarin is a **natural coumarin derivative** characterized by a farnesyl group at the 4-position of the coumarin core. Isolated primarily from Apiaceae and Rutaceae plants, it demonstrates multiple pharmacological activities. Recent studies highlight its **antitumor potential**, particularly as a **pro-apoptotic and anti-proliferative agent against cancer cells**. Mechanistically, it induces apoptosis via upregulation of caspase 3, p21, and p53, and may interfere with key oncogenic proteins including **GTPase KRas, Focal Adhesion Kinase 1, and Snail1**. It also displays **antioxidant properties** through free radical scavenging. 4-farnesyloxycoumarin’s main pharmaceutical challenge is low bioavailability, and current research focuses on nanoparticle and liposomal drug delivery systems to enhance its antitumor efficacy, especially against pancreatic, breast, and prostate cancer cells[1][3].

Other names

4-farnesyloxycoumarin4-FOC4-FLC